home / stock / bntx / bntx articles

BNTX Articles, BioNTech SE - From 10/16/23

Stock Information
Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de
Menu
BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories | Benzinga

Benzinga Bitcoin Spiked On False ETF Approval Rumor Bitcoin (BTC/USD), the ace cryptocurrency, spiked on unverified reports of the approval o...
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, se...

Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine | Benzinga

Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.&...

BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session | Benzinga

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. Ma...
Price Over Earnings Overview: BioNTech | Benzinga

In the current session, BioNTech Inc. (NASDAQ:BNTX) is trading at $108.00, after a 0.83% drop. Over the past month, the stock fell by 5.68%, and in...

A Look Into BioNTech Inc's Price Over Earnings | Benzinga

In the current session, BioNTech Inc. (NASDAQ:BNTX) is trading at $110.80, after a 0.13% decrease. Over the past month, the stock decreased by 2.64...

Privatized Vaccine Distribution Sparks Confusion, Payment Challenges | Benzinga

As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 ...
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute | Benzinga

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) ...

Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry | Benzinga

In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and...

Why Novavax Stock Fell Today | Benzinga

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency ...
Previous 10 Next 10